Bharat Immuno Key Ratios
BSE: 524663
₹15.27
₹-0.07
(-0.46%)
As on 07-Sep-2026IST
Market cap
₹66 Cr
Revenue (TTM)
₹45 Cr
P/E Ratio
--
P/B Ratio
--
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -43.09 | -12.61 | 5.09 |
| EBIT | -8.63 | -86.13 | -213.69 | -22.24 | -45.12 |
| Net Profit | -7.22 | -59.49 | -90.08 | -28.17 | -213.75 |
| EPS | -7.21 | -59.48 | -90.08 | -28.18 | -213.75 |
| Book Value | -- | -- | -260.27 | -204.00 | -190.71 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-23 | Mar-22 | Mar-21 |
| EBIT-Margin
| -22.60 | -19.04 | -36.47 | -6.62 | -24.73 |
| Net Margin
| -22.75 | -17.97 | -36.43 | -11.01 | -20.82 |
| Return on equity
| -52.88 | -43.11 | 0.00 | 0.00 | -158.64 |
| Return on Capital
| -35.58 | -27.86 | -25.63 | -8.08 | -73.05 |
| Return on Assets
| -11.39 | -10.07 | -9.41 | -6.35 | -18.41 |
| Debt to Equity (x)
| -- | -- | -3.05 | -12.18 | 11.56 |
Profitability
ROCE
-25.63
Lower than Peers by 25.34
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
|---|---|---|---|---|---|
|
Bharat Immuno
|
-25.63
|
-8.08
|
-73.05
|
-21.87
|
-10.70
|
|
Peer Median
|
-0.29
|
0.84
|
-0.26
|
2.65
|
5.79
|
ROE
--
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
|---|---|---|---|---|---|
|
Bharat Immuno
|
--
|
--
|
-158.64
|
-39.93
|
-17.00
|
|
Peer Median
|
-0.26
|
--
|
-2.89
|
1.07
|
4.01
|
ROA
-9.41
Lower than Peers by 5.99
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
|---|---|---|---|---|---|
|
Bharat Immuno
|
-9.41
|
-6.35
|
-18.41
|
-8.97
|
-7.22
|
|
Peer Median
|
-3.42
|
0.02
|
-5.58
|
0.79
|
2.90
|
EBIT Margin
-36.47
Lower than Peers by 46.51
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
|---|---|---|---|---|---|
|
Bharat Immuno
|
-36.47
|
-6.62
|
-24.73
|
-15.91
|
-11.47
|
|
Peer Median
|
10.05
|
6.96
|
20.93
|
9.77
|
9.71
|
Net Margin
-36.43
Lower than Peers by 29.01
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
|---|---|---|---|---|---|
|
Bharat Immuno
|
-36.43
|
-11.01
|
-20.82
|
-15.01
|
-6.59
|
|
Peer Median
|
-7.43
|
-2.61
|
-11.49
|
3.55
|
4.03
|
Cash Profit Margin
-36.85
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
|---|---|---|---|---|---|
|
Bharat Immuno
|
-36.85
|
-10.90
|
-20.95
|
-14.92
|
-6.60
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-43.09
Lower than Peers by 40.81
Year on year growth in net sales
|
Company Name
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
|---|---|---|---|---|---|
|
Bharat Immuno
|
-43.09
|
-8.14
|
27.68
|
-20.10
|
140.37
|
|
Peer Median
|
-2.29
|
7.94
|
1.99
|
-6.07
|
204.12
|
EBIT Growth
-213.69
Lower than Peers by 216.04
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
|---|---|---|---|---|---|
|
Bharat Immuno
|
-213.69
|
75.42
|
-98.40
|
-10.84
|
-15.01
|
|
Peer Median
|
2.35
|
-65.44
|
98.41
|
-6.19
|
9.86
|
Net Profit Growth
-90.08
Lower than Peers by 40.14
Year on year growth in profit after tax
|
Company Name
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
|---|---|---|---|---|---|
|
Bharat Immuno
|
-90.08
|
51.67
|
-77.38
|
-76.27
|
-35.93
|
|
Peer Median
|
-49.94
|
43.59
|
77.32
|
-64.50
|
14.62
|
EPS Growth
-90.08
Lower than Peers by 140.08
Year on year growth in earnings per share
|
Company Name
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
|---|---|---|---|---|---|
|
Bharat Immuno
|
-90.08
|
51.67
|
-77.38
|
-76.27
|
-35.93
|
|
Peer Median
|
50.00
|
-71.57
|
77.33
|
-64.25
|
14.62
|
Book Value Growth
-260.28
--
Year on year growth in book value per share
|
Company Name
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
|---|---|---|---|---|---|
|
Bharat Immuno
|
-260.28
|
-370.75
|
-88.47
|
-33.26
|
-18.18
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
-3.05
Lower than Peers by 3.36
Total debt / Net worth
|
Company Name
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
|---|---|---|---|---|---|
|
Bharat Immuno
|
-3.05
|
-12.18
|
11.56
|
0.15
|
1.05
|
|
Peer Median
|
0.31
|
0.30
|
0.46
|
0.24
|
0.81
|
Short term debt to equity ratio
0.80
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
|---|---|---|---|---|---|
|
Bharat Immuno
|
0.80
|
0.74
|
0.80
|
0.15
|
1.05
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
0.38
Lower than Peers by 0.79
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
|---|---|---|---|---|---|
|
Bharat Immuno
|
0.38
|
0.65
|
0.53
|
0.92
|
1.12
|
|
Peer Median
|
1.17
|
1.20
|
1.24
|
1.03
|
1.30
|
Quick Ratio
0.37
Lower than Peers by 0.69
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
|---|---|---|---|---|---|
|
Bharat Immuno
|
0.37
|
0.29
|
0.32
|
0.41
|
0.95
|
|
Peer Median
|
1.05
|
1.11
|
0.95
|
0.91
|
0.62
|
Interest Coverage
-2.15
Lower than Peers by 2.28
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
|---|---|---|---|---|---|
|
Bharat Immuno
|
-2.15
|
-0.73
|
-4.06
|
-1.99
|
-2.68
|
|
Peer Median
|
0.13
|
0.94
|
-0.37
|
1.40
|
1.69
|
Operating Efficiency
Debtors to sales
31.11
Higher than Peers by 5.99
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
|---|---|---|---|---|---|
|
Bharat Immuno
|
31.11
|
1.45
|
0.01
|
26.35
|
87.24
|
|
Peer Median
|
25.11
|
24.19
|
17.60
|
19.78
|
15.92
|
Asset Turnover
0.25
Lower than Peers by 0.13
Sales / Average Total Assets
|
Company Name
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
|---|---|---|---|---|---|
|
Bharat Immuno
|
0.25
|
0.57
|
0.87
|
0.59
|
1.04
|
|
Peer Median
|
0.38
|
0.42
|
0.67
|
0.46
|
0.96
|
Receivable days
61.40
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
|---|---|---|---|---|---|
|
Bharat Immuno
|
61.40
|
2.66
|
37.69
|
247.35
|
194.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
154.12
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
|---|---|---|---|---|---|
|
Bharat Immuno
|
154.12
|
115.80
|
139.46
|
180.65
|
35.26
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
8.90
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
|---|---|---|---|---|---|
|
Bharat Immuno
|
8.90
|
47.94
|
131.08
|
286.05
|
115.09
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
206.63
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
|---|---|---|---|---|---|
|
Bharat Immuno
|
206.63
|
70.53
|
46.07
|
141.95
|
114.17
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
|---|---|---|---|---|---|
|
Bharat Immuno
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
74.70
|
20.24
|
Price / Book Value
-4.16
Lower than Peers by 4.90
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
|---|---|---|---|---|---|
|
Bharat Immuno
|
-4.16
|
-18.98
|
83.21
|
1.23
|
1.08
|
|
Peer Median
|
0.74
|
1.53
|
2.11
|
1.03
|
0.91
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
|---|---|---|---|---|---|
|
Bharat Immuno
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-10.48
Lower than Peers by 24.22
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
|---|---|---|---|---|---|
|
Bharat Immuno
|
-10.48
|
-48.10
|
-11.12
|
-1.74
|
-11.29
|
|
Peer Median
|
13.74
|
-0.02
|
-6.48
|
13.31
|
7.36
|
Market Cap
96
Lower than Peers by 117
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
|---|---|---|---|---|---|
|
Bharat Immuno
|
96
|
121
|
196
|
25
|
33
|
|
Peer Median
|
213
|
263
|
637
|
155
|
56
|
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
